Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Clinical trial NCT01733394 · COMPLETED
Trial details
- NCT number
- NCT01733394
- Sponsor
- University of Cincinnati
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-12
- Primary completion
- 2016-09-26
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.